Biological and clinical features of patients from the Ma-Spore ALL 2003 trial genotyped for the <i>BIM</i> polymorphism.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Incidence of the BIM polymorphism is 50 out of 411 patients, or 12.2%. Abbreviations: Ma-Spore, Malaysia- Singapore; MRD, minimal residual disease; NCI, National Cancer Institute; PCR, polymerase chain reaction; CCR, continuous complete remission. ∧indicates that data was unavailable for some patients.
创建时间：
2014-08-04
